The UK is currently facing a meningitis outbreak, especially in the younger population. The outbreak started in Kent, south-east of England, and the UK Health Security Agency (UKHSA) is investigating the outbreak. As of 24 March, 20 laboratory cases were confirmed, with two under investigation. Meningitis is rare in the UK, so it is unusual to have more than 20 cases in one small geographical area. It began on March 15, when the UKHSA issued a public health alert regarding an outbreak of meningitis. It was believed that all the initial cases were linked to a wave of young people attending a nightclub. It was later confirmed that the strain was meningitis B. Due to this outbreak, there is renewed initiative on vaccination coverage against meningitis.
Meningitis is a life-threatening condition caused by a bacterial or viral infection of the protective membranes surrounding the brain and spinal cord, primarily affecting babies, young children, teenagers, and young adults. Meningitis can be very serious if not treated quickly. According to the WHO, meningitis remains a significant global health threat even though treatments and vaccines against some forms of meningitis are available. Bacterial meningitis is the most dangerous form and can become life-threatening within 24 hours. The WHO recently launched the first-ever guidelines for the diagnosis and management of bacterial meningitis to reduce lifelong complications and mortality in the affected individuals and communities. The guideline is a contribution to the wider goals of the WHO to defeat meningitis by 2030. To achieve these goals, countries such as the UK need to develop a system of faster diagnosis and treatment, prevention, and epidemic control through disease surveillance, care, and support for suspected cases, and greater public awareness campaigns.
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
Meningitis vaccination provides effective protection and minimises the probability of outbreaks. The current outbreak in the UK is now under control, but the threat remains from this infection. Global Data epidemiologists forecast that the laboratory-confirmed diagnosed incident cases of invasive meningococcal disease caused by the bacterium Neisseria meningitidis in the UK will be approximately 800 cases in 2026, which will remain unchanged in 2029. Meningitis cases are relatively rare due to effective vaccination and early treatment; however, the UKHSA still needs to be vigilant for similar outbreaks in the future.
